MIPI C-PHY v1.2 D-PHY v2.1 TX 3 trios/4 Lanes in TSMC (16nm, 12nm, N7, N6, N5, N3E)
Xilinx sees the logic of Triscend acquisition
Xilinx sees the logic of Triscend acquisition
By Peter Clarke, Silicon Strategies
March 8, 2004 (1:12 p.m. EST)
URL: http://www.eetimes.com/story/OEG20040308S0019
SAN JOSE, Calif. Xilinx Inc. said Monday (March 8) it has signed an agreement to acquire Triscend Corp., a developer of configurable embedded microcontrollers that combine ARM processor cores with field programmable logic. Triscend had been the subject of a merger agreement with ARM Holdings plc that collapsed in February 2004. The majority of Triscend's 40 employees, currently located at the company's headquarters in Mountain View, Calif., would become Xilinx employees, Xilinx said. The company anticipates booking the acquisition in its fiscal fourth quarter ending April 3, 2004. At that time, the purchase price allocation would be recorded. Financial details of the deal were not disclosed. "The significant talent and technology at the core of Triscend will strengthen our efforts in the embedded processing space, accelerating future development of embedded solutions and speeding our market ramp in this important emerging market," said Erich Goetting, vice president and general manager of Xilinx' advanced product division.
Related News
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |